Value Bridge — WINCHESTER MEDICAL CENTER
Current $-41M → Target $-25M (+$15.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-40.6M
Current EBITDA
$-25.2M
Target EBITDA
+$15.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.5M
Payer Mix Optimization
$8.3M
Cost to Collect Reduction
$2.8M
Clean Claim Improvement
$2.1M
Volume & Rate Growth
$13.9M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-41M to $-25M. The highest-impact lever is Volume & Rate Growth at $5.6M probability-weighted.
IC talking point: "We see $15M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $169M in equity value creation."